ペニルプリカの内腔フェニルフリン投与後の遅延性高血圧危機
1Department of Anaesthesiology University of North Carolina Chapel Hill NC USA.
Anaesthesia reports
|September 5, 2025
まとめ
陰茎の折りたたみ中にフェニルエフリンの内腔注射は,遅延した高血圧の緊急事態を引き起こす可能性があります. この Peyronie 治療の後の血液動力学的変化の管理には,手術後の注意深いモニタリングが不可欠です.
科学分野:
- 泌尿器科
- 薬理学について
- 心血管医学
背景:
- ペイロニー病におけるペニル縮の標準は,血管収縮による解消を助長する.
- 系統的吸収は可能ですが,プリアピズムに対する高用量は,希少な血液動力学的問題で良好な安全性プロファイルを示しています.
研究 の 目的:
- ペイロニー病のペニル縮の際に,手術中の内フェニルエフリン注射後に遅延した高血圧の緊急事態を報告する.
- 血動力学的不安定性に対する 警戒的な術後モニタリングの必要性を強調する
主な方法:
- 68歳の男性患者に 歩行器のペニスの折りたたみが行われました
- 内フェニルフリン注射が施されました.
- 術後のモニタリングが行われました.
主要な成果:
- 患者は手術後90分後に高血圧の緊急事態を経験した.
- これは,遅れた血液動力学的合併症の可能性を強調します.
結論:
- 外科手術中の内フェニルフリンは,遅延した高血圧の緊急事態を引き起こす可能性があります.
- 内フェニルエフリン注射によるペニル縮後の慎重な術後のモニタリングは不可欠です.
さらに関連する動画
関連する概念動画
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
246
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
246
Antihypertensive Drugs: Vasodilators
642
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
642
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
223
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
223
Male Sexual Response: Erection & Ejaculation
4.7K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
4.7K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
250
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
250
Cardiac Catheterization I: Pre-Procedure Overview
153
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
153


